Teduglutide in Short Bowel Syndrome Patients

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Short Bowel Syndrome Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Malabsorption Syndromes Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

SBS-IF

Exclusion criteria

< 18 years
Incompliance
< 6 months of treatment

Treatment and study plan

Teduglutide

Drug

effect of teduglutide on intestinal rehabilitation

Primary outcomes

enteral autonomy

Time frame: at least 6 months of teduglutide treatment

percentage of patients reaching complete discontinuation of parenteral support

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Teduglutide in Short Bowel Syndrome Patients - A Way Back to Normal Life?

Important dates

Study start: 2016
Primary completion: 2020
Study completion: 2020
First posted: Apr 23, 2021
Registry last updated: Apr 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed